441 related articles for article (PubMed ID: 11953698)
1. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.
Kaukinen K; Sulkanen S; Mäki M; Collin P
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698
[TBL] [Abstract][Full Text] [Related]
2. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
[TBL] [Abstract][Full Text] [Related]
3. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
[TBL] [Abstract][Full Text] [Related]
4. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
5. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet.
Bazzigaluppi E; Roggero P; Parma B; Brambillasca MF; Meroni F; Mora S; Bosi E; Barera G
Dig Liver Dis; 2006 Feb; 38(2):98-102. PubMed ID: 16386476
[TBL] [Abstract][Full Text] [Related]
7. Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
Auricchio R; Mandile R; Del Vecchio MR; Scapaticci S; Galatola M; Maglio M; Discepolo V; Miele E; Cielo D; Troncone R; Greco L
Gastroenterology; 2019 Aug; 157(2):413-420.e3. PubMed ID: 30978358
[TBL] [Abstract][Full Text] [Related]
8. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
[TBL] [Abstract][Full Text] [Related]
9. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
Akbari MR; Mohammadkhani A; Fakheri H; Javad Zahedi M; Shahbazkhani B; Nouraie M; Sotoudeh M; Shakeri R; Malekzadeh R
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1181-6. PubMed ID: 17033439
[TBL] [Abstract][Full Text] [Related]
10. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
[TBL] [Abstract][Full Text] [Related]
11. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease.
Koskinen O; Lindfors K; Collin P; Peräaho M; Laurila K; Woolley N; Partanen J; Mäki M; Kaukinen K
Dig Liver Dis; 2010 Oct; 42(10):692-7. PubMed ID: 20409763
[TBL] [Abstract][Full Text] [Related]
12. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
[TBL] [Abstract][Full Text] [Related]
13. Altered small-bowel mucosal vascular network in untreated coeliac disease.
Myrsky E; Syrjänen M; Korponay-Szabo IR; Mäki M; Kaukinen K; Lindfors K
Scand J Gastroenterol; 2009; 44(2):162-7. PubMed ID: 18985542
[TBL] [Abstract][Full Text] [Related]
14. Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up.
Sharkey LM; Corbett G; Currie E; Lee J; Sweeney N; Woodward JM
Aliment Pharmacol Ther; 2013 Nov; 38(10):1278-91. PubMed ID: 24117503
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
[TBL] [Abstract][Full Text] [Related]
16. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.
Leonard MM; Weir DC; DeGroote M; Mitchell PD; Singh P; Silvester JA; Leichtner AM; Fasano A
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):286-291. PubMed ID: 28112686
[TBL] [Abstract][Full Text] [Related]
17. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease.
Vetrano S; Zampaletta U; Anania MC; Di Tola M; Sabbatella L; Passarelli F; Maffia C; Sanjust MG; Lettieri F; De Pità O; Picarelli A
Dig Liver Dis; 2007 Oct; 39(10):911-6. PubMed ID: 17719860
[TBL] [Abstract][Full Text] [Related]
19. Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.
Ruuskanen A; Luostarinen L; Collin P; Krekelä I; Patrikainen H; Tillonen J; Laurila K; Haimila K; Partanen J; Mäki M; Valve R; Kaukinen K
Dig Liver Dis; 2011 Oct; 43(10):772-8. PubMed ID: 21641886
[TBL] [Abstract][Full Text] [Related]
20. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.
Korponay-Szabó IR; Halttunen T; Szalai Z; Laurila K; Király R; Kovács JB; Fésüs L; Mäki M
Gut; 2004 May; 53(5):641-8. PubMed ID: 15082580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
